Cellusion Inc.

Cellusion have developed three main technologies for solving global cornea shortage issue, which are novel cell transplantation method for Bullous Keratopathy treatment, mass production technology to produce corneal endothelial cell from iPS cells, spheroid transplantation method to enhance the treatment efficacy. With these cellular technology breakthroughs, we will contribute to provide the clear vision of the future for worldwide patients.